340B Drug Program: Key Trends for 2023 | Baker Donelson
Throughout 2022, the 340B Drug Program (340B) and participating hospital systems experienced myriad new developments. From continued disputes with drug manufacturers to a landmark U.S....
Stay updated with breaking news from Covered Entity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Throughout 2022, the 340B Drug Program (340B) and participating hospital systems experienced myriad new developments. From continued disputes with drug manufacturers to a landmark U.S....
The Securities and Exchange Commission released several proposals all aimed at bolstering different aspects of cybersecurity in the securities market.
<p><span>Thank you, Chair Gensler. No one questions the threat cybercriminals pose to our capital markets, and the need for broker-dealers and other regulated entities to protect themselves and their customers and counterparties from cyberthreats. As the proposing release notes, there are considerable reputational, psychological, and financial costs associated with these breaches.</span><span> Increasing reliance on technology in our markets has only heightened how important it is for firms to take steps to prevent cyberattacks and mitigate their effects. Addre...
This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases...
On February 1, 2023, the Federal Trade Commission (FTC) filed a complaint in the U.S. District Court for the Northern District of California alleging that digital health platform GoodRx...